The Chamber of Foreign Trade also extended, until the end of October, zero tariffs for the import of 562 items. Vaccines are still being studied in the world; government predicts distribution in 2021.

The Foreign Trade Chamber (Camex) of the Ministry of Economy decided on this Thursday (17th) to include vaccines against Covid-19 and the inputs for manufacturing vaccines in the list of products with zero import tariffs.

The decision was published in the “Diário Oficial da União” and is valid until the end of October, but can be renewed.

Vaccines against the new coronavirus are still being studied in several countries around the world, including England, China, United States, Russia e Brazil (click on the country name to find out more details about the studies).

According to the director of the Butantan Institute, Dimas Covas, the institute will receive this year 15 million doses of the vaccine Chinese CoronaVac.

The release for use of the vaccine in the population, however, will depend on the result of clinical tests and the approval of the National Health Surveillance Agency (Anvisa).

In the case of the vaccine developed by the University of Oxfordin the United Kingdom, the Ministry of Health predicts that distribution will take place in January 2021.

Coronavirus products

In addition to including vaccines against Covid-19 in the list of products with zero tariffs, Camex also decided to extend, from the end of September to the end of October, the import tax zeroed for 562 products used to prevent and combat the coronavirus .

According to the Ministry of Economy, the list includes medicines and medical and hospital products as well as inputs, as well as components and accessories used in the manufacture and operation of items used during the pandemic of the new coronavirus.

“The objective of the measure is to increase the supply of goods destined to fight the pandemic, in addition to machines and inputs used in the national manufacture of these products. In this way, the government is increasing availability and decreasing costs for the Brazilian health system ”, added the government.